Abstract
Genome-wide studies for decoding molecular mechanisms of tumor cell-host interactions associated with cancer progression have revealed a determinant role for exosome-mediated intercellular communications in metastasis signaling. Exosomes are specialized plasma membrane-bound nanovesicles secreted under physiological conditions by various cells to regulate tissue homeostasis and immune response. In cancer, overproduction of exosomes and/or changes in their contents are common features of many cancer cell types and can bear unique molecular signatures reminiscent to the cancer phenotype. Exosomes mediate paracrine signaling required for cross-talks between tumor cells and the host stromal and infiltrating inflammatory and immune cells within the tumor tissue microenvironment as well as distant metastatic niches. Exosomes promote cancer invasiveness at multiple levels of the metastatic cascades favoring a permissive environment for cell survival and growth. This review focuses specifically on the implication of cancer-associated exosomes for cell signaling that promotes metastasis development. For detailed biochemical and molecular studies addressing exosome biology, we refer the reader to selected seminal studies in the field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Alix:
-
ALG-2-interacting protein X
- c-Met:
-
Hepatocyte growth factor receptor
- EGFR:
-
Epidermal growth factor receptor
- FasL:
-
Fas ligand
- HER-2:
-
Human epidermal growth factor receptor 2
- HIF-1α:
-
Hypoxia-inducible factor 1-alpha
- hnRNPA2B1:
-
Heterogeneous nuclear ribonucleo protein A2B1
- ICAM1:
-
Intercellular adhesion molecule 1
- LAMP:
-
Lysosome-associated membrane protein
- LFA1:
-
Lymphocyte function-associated antigen 1
- Mdh1:
-
Malate dehydrogenase 1
- MDR1:
-
Multidrug resistance protein 1
- MFGE8:
-
Milk fat globule-EGF factor 8 protein
- MMP:
-
Matrix metallopeptidase
- MVB:
-
Multivesicular bodies
- PD-1:
-
Programmed cell death protein 1
- Pgm1:
-
Phosphoglucomutase
- PK:
-
Pyruvate kinases
- TGF-β:
-
Transforming growth factor beta
- TGF-βR:
-
Transforming growth factor beta receptor
- TNFα:
-
Tumor necrosis factor-alpha
- Tsg101:
-
Tumor susceptibility gene 101 protein
- VEGF:
-
Vascular endothelial growth factor
- VEGR:
-
Vascular endothelial growth factor receptor
References
Raiborg C, Stenmark H (2009) The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458:445–452
Hurley JH, Hanson PI (2010) Membrane budding and scission by the ESCRT machinery: it’s all in the neck. Nature Rev Mol Cell Biol 11:556–566
Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brügger B, Simons M (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319(5867):1244–1247. doi:10.1126/science.1153124
Denzer K, Kleijmeer MJ, Stoorvodel W, Heijnen HF, Geuze HJ (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113:3365–3374
Record M, Subra C, Silvente-Poirot S, Poirot M (2011) Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 81:1171–1182
Simpson RJ, Jensen SS, Lim JW (2008) Proteomic profiling of exosomes: current perspectives. Proteomics 8(19):4083–4099. doi:10.1002/pmic.200800109
Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, Goud B, Benaroch P, Hacohen N, Fukuda M, Desnos C, Seabra MC, Darchen F, Amigorena S, Moita LF, Thery C (2010) Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 12(1):19–30. doi:10.1038/ncb2000
Savina A, Fader CM, Damiani MT, Colombo MI (2005) Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic 6:131–143
Lebrand C, Corti M, Goodson H, Cosson P, CavalliV MN, Faure J, Gruenberg J (2002) Late endosome motility depends on lipids via the small GTPase Rab7. EMBO J 21:1289–1300
Conde-Vancells J, Rodriguez-Suarez E, Embade N, Gil D, Matthiesen R, Valle M, Elortza F, Lu SC, Mato JM, Falcon-Perez JM (2008) Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res 7(12):5157–5166
Raposo G, Stoorvogel W (2013) Extracellular vesicles:exosomes, microvesicles, and friends. J Cell Biol 200:373–383
Valadi H et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659
Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110(1):13–21
Lehmann BD et al (2008) Senescence-associated exosome release from human prostate cancer cells. Cancer Res 68(19):7864–7871
Skog J et al (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10(12):1470–1476
Lässer C, Alikhani VS, Ekström K et al (2011) Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med 9:9
Kogure T, Lin WL, Yan IK et al (2011) Intercellular nanovesicle-mediated microRNA transfer:a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 54(4):1237–1248
Montecalvo A, Larregina AT, Shufesky WJ et al (2012) Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119(3):756–766
Simpson RJ, Kalra H, Mathivanan S (2012) ExoCarta as a resource for exosomal research. J Extracell Vesicles. doi:10.3402/jev.v1i0.18374
Paget S (1989) The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 8(2):98–101
Bobrie A, Théry C (2013) Unraveling the physiological functions of exosome secretion by tumors. Oncoimmunology 2(1):e22565
Koga K, Matsumoto K, Akiyoshi T, Kubo M, Yamanaka N, Tasaki A, Nakashima H, Nakamura M, Kuroki S, Tanaka M, Katano M (2005) Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res 25(6A):3703–3707
Christianson HC, Svensson KJ, van Kuppevelt TH, Li J-P, Belting M (2013) Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc Natl Acad Sci U S A 110(43):17380–17385
Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2(6):442–454
Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871–890. doi:10.1016/j.cell.2009.11.007
Kalluri R1, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119(6):1420–1428. doi:10.1172/JCI39104
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704–715. doi:10.1016/j.cell.2008.03.027
Chaffer CL1, Marjanovic ND, Lee T, Bell G, Kleer CG, Reinhardt F, D’Alessio AC, Young RA, Weinberg RA (2013) Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154(1):61–74. doi:10.1016/j.cell.2013.06.005
Thiery JP, Lim CT (2013) Tumor dissemination: an EMT affair. Cancer Cell 23(3):272–273. doi:10.1016/j.ccr.2013.03.004
Aga M, Bentz GL, Raffa S, Torrisi MR, Kondo S, Wakisaka N, Yoshizaki T, Pagano JS, Shackelford J (2014) Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes. Oncogene. doi:10.1038/onc.2014.66
Gu J, Qian H, Shen L, Zhang X, Zhu W, Huang L, Yan Y, Mao F, Zhao C, Shi Y, Xu W (2012) Gastric cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-associated fibroblasts through TGF-β/Smad pathway. PLoS One 7(12), e52465. doi:10.1371/journal.pone.0052465
Ramteke A, Ting H, Agarwal C, Mateen S, Somasagara R, Hussain A, Graner M, Frederick B, Agarwal R, Deep G (2013) Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules. Mol Carcinog. doi:10.1002/mc.22124
Jeppesen DK, Nawrocki A, Jensen SG, Thorsen K, Whitehead B, Howard KA, Dyrskjøt L, Ørntoft TF, Larsen MR, Ostenfeld MS (2014) Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors. Proteomics 14(6):699–712. doi:10.1002/pmic.201300452
Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M, Wrana JL (2012) Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151(7):1542–1556. doi:10.1016/j.cell.2012.11.024
Mu W, Rana S, Zöller M (2013) Host matrix modulation by tumor exosomes promotes motility and invasiveness. Neoplasia 15(8):875–887
Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC, Tetta C, Bussolati B, Camussi G (2011) Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 71(15):5346–5356. doi:10.1158/0008-5472.CAN-11-0241
Hood JL, San RS, Wickline SA (2011) Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 71(11):3792–3801
Webber J, Steadman R, Mason MD, Tabi Z, Clayton A (2010) Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 70(23):9621–9630. doi:10.1158/0008-5472.CAN-10-1722, Epub 2010 Nov 23
Robbins PD (2014) Morelli AE regulation of immune responses by extracellular vesicles. Nat Rev Immunol 14(3):195–208
Ochoa AC, Zea AH, Hernandez C, Rodriguez PC (2007) Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 13(2 Pt 2):721s–726s
Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, Boireau W, Rouleau A, Simon B, Lanneau D, De Thonel A, Multhoff G, Hamman A, Martin F, Chauffert B, Solary E, Zitvogel L, Garrido C, Ryffel B, Borg C, Apetoh L, Rébé C, Ghiringhelli F (2010) Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest 120(2):457–471. doi:10.1172/JCI40483. Epub Jan 19
Hong EH, Chang SY, Lee BR, Kim YS, Lee JM, Kang CY, Kweon MN, Ko HJ (2013) Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells. J Cancer Educ 132(12):2839–2848. doi:10.1002/ijc.27974
Liu C, Yu S, Zinn K, Wang J, Zhang L, Jia Y, Kappes JC, Barnes S, Kimberly RP, Grizzle WE, Zhang HG (2006) Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 176(3):1375–1385
Taylor DD, Gerçel-Taylor C, Lyons KS, Stanson J, Whiteside TL (2003) T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors. Clin Cancer Res 9(14):5113–5119
Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, Corbelli A, Fais S, Parmiani G, Rivoltini L (2006) Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res 66(18):9290–9298
Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56(11):1733–1741. doi:10.1373/clinchem.2010.147405
Keller S, Ridinger J, Rupp AK, Janssen JW, Altevogt P (2011) Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med 9:86. doi:10.1186/1479-5876-9-86
Villarroya-Beltri C, Gutiérrez-Vázquez C, Sánchez-Cabo F, Pérez-Hernández D, Vázquez J, Martin-Cofreces N, Martinez-Herrera DJ, Pascual-Montano A, Mittelbrunn M, Sánchez-Madrid F (2013) Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun 4:2980. doi:10.1038/ncomms3980
Pegtel DM, Cosmopoulos K, Thorley-Lawson DA et al (2010) Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 107(14):6328–6333
Pan Q, Ramakrishnaiah V, Henry S et al (2011) Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi). Gut 61(9):1330–1339. doi:10.1136/gutjnl-2011-300449
Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, Sun F, Lu J, Yin Y, Cai X, Sun Q, Wang K, Ba Y, Wang Q, Wang D, Yang J, Liu P, Xu T, Yan Q, Zhang J, Zen K, Zhang CY (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39(1):133–144. doi:10.1016/j.molcel.2010.06.010
Yang M, Chen J, Su F et al (2011) Microvesicles secreted by macrophages shuttle invasion potentiating microRNAs into breast cancer cells. Mol Cancer 10:117
Fabbri M, Paone A, Calore F, Galli R, Croce CM (2013) A new role for microRNAs, as ligands of Toll-like receptors. RNA Biol 10(2):169–174
Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G et al (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 8(6):883–891. doi:10.1038/nm.2753
Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin PJ (2009) Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer 9:244. doi:10.1186/1471-2407-9-244
Lu Q, Zhang J, Allison R, Gay H, Yang WX, Bhowmick NA, Frelix G, Shappell S, Chen YH (2009) Identification of extracellular delta-catenin accumulation for prostate cancer detection. Prostate 69(4):411–418. doi:10.1002/pros.20902
Morrissey JJ, London AN, Luo J, Kharasch ED (2010) Urinary biomarkers for the early diagnosis of kidney cancer. Mayo Clin Proc 85(5):413–421. doi:10.4065/mcp.2009.0709
Qu JL1, Qu XJ, Zhao MF, Teng YE, Zhang Y, Hou KZ, Jiang YH, Yang XH, Liu YP (2009) Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig Liver Dis 41(12):875–880. doi:10.1016/j.dld.2009.04.006
Klinke DJ 2nd, Kulkarni YM, Wu Y, Byrne-Hoffman C (2014) Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models. Biotechnol Bioeng. doi:10.1002/bit.25238
Ciravolo V, Huber V, Ghedini GC, Venturelli E, Bianchi F, Campiglio M, Morelli D, Villa A, Della Mina P, Menard S, Filipazzi P, Rivoltini L, Tagliabue E, Pupa SM (2012) Potential role f HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol 227(2):658–667. doi:10.1002/jcp.22773
Klein-Scory S, Kübler S, Diehl H, Eilert-Micus C, Reinacher-Schick A, Stühler K, Warscheid B, Meyer HE, Schmiegel W, Schwarte-Waldhoff I (2010) Immunoscreening of the extracellular proteome of colorectal cancer cells. BMC Cancer 10:70. doi:10.1186/1471-2407-10-70
Schwarzenbach H, Nishida N, Calin GA, Pantel K (2014) Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 11(3):145–156
Marleau AM, Chen CS, Joyce JA, Tullis RH (2012) Exosome removal as a therapeutic adjuvant in cancer. J Transl Med 10:134. doi:10.1186/1479-5876-10-134
Grapp M, Wrede A, Schweizer M, Hüwel S, Galla HJ, Snaidero N, Simons M, Bückers J, Low PS, Urlaub H, Gärtner J, Steinfeld R (2013) Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma. Nat Commun 4:2123. doi:10.1038/ncomms3123
Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341–345. doi:10.1038/nbt.1807
Delcayre A, Estelles A, Sperinde J, Roulon T, Paz P, Aguilar B, Villanueva J, Khine S, Le Pecq JB (2005) Exosome display technology: applications to the development of new diagnostics and therapeutics. Blood Cells Mol Dis 35(2):158–168
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Cao, Y.H., Bijian, K., Alkailani, M.I., Alaoui-Jamali, M.A. (2015). Tumor-Derived Exosomes in Metastasis Signaling and Implications. In: Kandouz, M. (eds) Intercellular Communication in Cancer. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7380-5_7
Download citation
DOI: https://doi.org/10.1007/978-94-017-7380-5_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7379-9
Online ISBN: 978-94-017-7380-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)